NewsBenzingaBTIG reitera su recomendación de compra sobre Serina Therapeutics y mantiene un precio objetivo de 8 dólares. BTIG reitera su recomendación de compra sobre Serina Therapeutics y mantiene un precio objetivo de 8 dólares. Benzinga 2026.10.26 09:51 (GMT+0) Open on Benzinga Other news Freedom Broker Maintains Buy on XPeng, Lowers Price Target to $20 Plug Power Shares Slide Toward 52-Week Low Despite New 280-MW Texas Deal Nvidia Vs. Anthropic: Can the AI IPO Challenge Nvidia’s Dominance Across ETFs? Freedom Broker Maintains Buy on Allot, Lowers Price Target to $12.7 Freedom Broker Maintains Hold on Skydance, Lowers Price Target to $8.5 Freedom Broker Upgrades M-Tron Industries to Buy, Lowers Price Target to $84